![Richard J. White](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard J. White
Directeur Technique/Scientifique/R&D chez Vicuron Pharmaceuticals LLC
Postes actifs de Richard J. White
Sociétés | Poste | Début | Fin |
---|---|---|---|
Vicuron Pharmaceuticals LLC
![]() Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Directeur Technique/Scientifique/R&D | 01/01/1997 | - |
Indel Therapeutics, Inc.
![]() Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Directeur/Membre du Conseil | 29/04/2011 | - |
Historique de carrière de Richard J. White
Anciens postes connus de Richard J. White
Sociétés | Poste | Début | Fin |
---|---|---|---|
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | - | 24/11/2010 |
Président | 24/11/2010 | 01/12/2018 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1985 | 01/01/1997 |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - | - |
Glaxo Group Research Ltd. | Corporate Officer/Principal | - | - |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | - | - |
Formation de Richard J. White
University of Oxford | Doctorate Degree |
The University of Manchester | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 4 |
Israël | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 6 |
---|---|
Vicuron Pharmaceuticals LLC
![]() Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
Glaxo Group Research Ltd. | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Indel Therapeutics, Inc.
![]() Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. |
- Bourse
- Insiders
- Richard J. White
- Expérience